As we get over the hump of third-quarter financial reports, Scrip has taken a look at updates from the big PD-1/PD-L1 players, creating a handy calendar of key data readouts to watch for this winter and into 2017.
According to Informa Pharma Intelligence's Trialtrove database there are currently 904 ongoing clinical trials for immuno-oncology agents in the US...







![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)